Bafna Pharmaceuticals Ltd.

Financial

	Bafna Pharma	Chemkart India	Ambalal Sarabhai Ent
Operational Metrics
Financials
5 yr Average ROE	-52.11 %	57.15 %	19.11 %
5yr average Equity Multiplier	3.77	2.41	2.07
5yr Average Asset Turnover Ratio	0.42	2.97	0.75
5yr Avg Net Profit Margin	-36.55 %	8.77 %	10.89 %
Price to Book	5.15	4.86	1.85
P/E	31.81	10.67	20.24
5yr Avg Cash Conversion Cycle	0.18 Days	74.43 Days	-37.53 Days
Inventory Days	87.65 Days	17.49 Days	33.51 Days
Days Receivable	132.64 Days	69.5 Days	63.69 Days
Days Payable	210.48 Days	31.94 Days	147.98 Days
5yr Average Interest Coverage Ratio	-5.68	26.3	9.88
5yr Avg ROCE	-11.61 %	78.81 %	24.01 %
5yr Avg Operating Profit Margin	-21.98 %	12.11 %	5.29 %
5 yr average Debt to Equity	1.41	0.59	0.32
5yr CAGR Net Profit	12.0 %	34.67 %	-30.01 %
5yr Average Return on Assets	-16.11 %	24.52 %	8.69 %
Shareholdings
Promoter Holding	75.0 %	73.31 %	31.35 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-15.12 %	0.0	0.59 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Bafna Pharma	Chemkart India	Ambalal Sarabhai Ent
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Vitamin 0 Sports Nutrition 0 Protein 0 Nucleotide 0 Herbal Extract 0 Health Supplement 0 Amino Acids 0 Electronics 0	Product Wise Break-Up Pharmaceuticals 0 Protein 3.04 Health Supplement 11.86 Herbal Extract 1.63 Sports Nutrition 33.23 Nucleotide 0.88 Electronics 0 Amino Acids 44.4 Vitamin 2.29 Others 2.67	Product Wise Break-Up Pharmaceutical 43.74 Protein 0 Health Supplement 0 Herbal Extract 0 Sports Nutrition 0 Nucleotide 0 Electronics 56.26 Amino Acids 0 Vitamin 0